PTSD and Addiction: Trauma-Informed Care for Co-Occurring Disorders
Plain, fact-first answers about how care works here. Want to talk to a person? Call (888) 464-2144.
- The Archangel Centers is a licensed outpatient addiction treatment provider.
- The Archangel Centers operates clinics in Tinton Falls, NJ and Charlotte, NC.
- PTSD with co-occurring substance use disorder is part of the outpatient continuum at The Archangel Centers.
- PTSD and substance use disorder are treated together in an integrated dual-diagnosis treatment plan.
- Integrated dual-diagnosis care is delivered by the same clinical team from intake.
- Medication-assisted treatment (MAT) includes Suboxone, Vivitrol, and Sublocade.
- The Archangel Centers works with most major commercial insurance plans with free benefits verification.
Post-traumatic stress disorder (PTSD) and substance use disorder (SUD) are among the highest-prevalence co-occurring pairs seen in adult addiction treatment. The pattern is consistent across the clinical literature: trauma symptoms drive substance use as a coping tool, substance use complicates trauma processing, and the two conditions reinforce each other over years. Untreated PTSD is one of the strongest predictors of relapse, and untreated SUD is one of the strongest barriers to durable trauma recovery.
Despite the strength of the evidence, PTSD is frequently missed at the SUD intake door. Clients arrive presenting alcohol, opioid, benzodiazepine, cannabis, or stimulant use as the problem; the trauma history surfaces later, sometimes weeks into treatment, sometimes only after a relapse. Programs that do not screen for trauma at admission or do not staff for trauma-informed care often treat the substance and miss the driver underneath.
This guide explains what PTSD is in clinical terms, how trauma and substance use interact, what the warning signs of co-occurring PTSD and SUD look like, and what integrated outpatient treatment looks like across the continuum of care. This page is informational. If you are looking for treatment, see the levels of care explained section, or call (888) 464-2144 to speak with admissions at The Archangel Centers.
What PTSD is
In the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the American Psychiatric Association defines post-traumatic stress disorder as a constellation of symptoms that follow a qualifying traumatic exposure. The exposure can be direct (experiencing the event), witnessed (seeing it happen to someone else), or indirect (learning that it happened to a close family member or friend, or repeated exposure to traumatic material in the course of professional duty).
To meet diagnostic criteria, symptoms must persist for at least one month after the exposure, produce clinically significant distress or functional impairment, and fall across four symptom clusters:
Lifetime prevalence of PTSD in U.S. adults is approximately 6.8 percent according to Kessler and colleagues at the National Comorbidity Survey Replication. About 70 percent of U.S. PTSD cases are not combat-related; PTSD in civilian populations is driven by interpersonal violence, accidents, medical events, childhood adversity, and sexual assault. Sexual assault carries the highest conditional risk: roughly 45 percent of survivors meet criteria for PTSD at some point.
- Intrusion: recurrent intrusive memories, distressing dreams or nightmares, flashbacks in which the person feels the event is recurring, intense psychological distress at reminders, and physiological reactivity to reminders
- Avoidance: persistent effort to avoid trauma-related thoughts and feelings, and avoidance of external reminders (people, places, situations) that trigger them
- Negative cognitions and mood: inability to remember key features of the event, persistent negative beliefs about oneself or the world, distorted blame, persistent fear, anger, guilt, or shame, loss of interest in significant activities, detachment from others, and inability to feel positive emotions
- Arousal and reactivity: irritability or aggression, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbance
How trauma and substance use interact
The neurobiology behind co-occurring PTSD and SUD is well-characterized. A traumatic event that is not processed and integrated leaves the nervous system in a dysregulated state: the threat-response circuitry remains primed, the body cycles between hyperarousal (anxiety, vigilance, insomnia, agitation) and hypoarousal (numbing, dissociation, depression), and the window of tolerance for ordinary stress narrows. Substances enter this picture as regulators. Alcohol and benzodiazepines blunt hyperarousal. Opioids dampen emotional pain. Stimulants compensate for the fatigue and depression of hypoarousal. Cannabis numbs intrusive memories and helps with sleep.
The relief is real, which is why the pattern is so durable. The cost is that substances interrupt the natural processing of traumatic memory, lock the nervous system into the dysregulated state they were used to manage, and add a second disorder on top of the first. Over months and years, the person becomes less able to tolerate any internal experience without using, and the trauma symptoms intensify in the periods between use.
This is why treating SUD alone, without addressing the underlying PTSD, produces poor outcomes for trauma-positive clients. Sobriety removes the regulator, exposes the dysregulated nervous system, and produces an intense return of trauma symptoms that the client has no skills to manage. Relapse, in that context, is not a moral failure. It is a predictable consequence of a treatment plan that addressed half the problem.
Signs and symptoms of co-occurring PTSD and SUD
What does the combination look like in everyday life? Co-occurring PTSD and SUD tends to present with patterns that pure SUD or pure PTSD does not, including:
- Drinking or using to get to sleep, especially to suppress nightmares or middle-of-the-night intrusions
- Substance use that escalates around anniversaries of the traumatic event, contact with reminders, or after exposure to news of similar events
- Repeated cycles of sobriety followed by relapse during periods of high trauma-symptom activity
- A pattern of choosing substances based on what they suppress: alcohol or benzodiazepines for hyperarousal, opioids for emotional pain, stimulants for depression, cannabis for intrusive memories
- Avoidance behavior that the client may attribute to the addiction (isolating, missing work, declining invitations) but that has trauma underneath it
- Strong startle response, scanning of environments, or sitting where exits are visible, alongside the substance use pattern
- Difficulty with intimacy and relationships, often with a history that predates the substance use
- Self-medication that started in adolescence, especially in the years immediately after a traumatic event
- Suicidal thoughts that intensify during periods of attempted sobriety
Why a substance-only program fails PTSD-positive clients
Programs that treat the substance without staffing for trauma create a specific set of failure modes for PTSD-positive clients. The first is re-traumatization. Group settings that pressure disclosure, confrontational styles of feedback, lack of exit visibility, and crowded rooms can all trigger trauma responses in clients who are not yet stabilized enough to manage them. The client leaves treatment more dysregulated than they arrived.
The second is premature trauma narrative work. Some programs jump into detailed trauma history within the first days of treatment, before the client has the grounding skills, distress tolerance, or window of tolerance to process what comes up. The result is a client who is flooded, who relapses to manage the flood, and who concludes that talking about the trauma made things worse. In a real sense, it did.
The third is triggers without skills. Sobriety alone surfaces every cue and every memory that substances were suppressing. A program that does not equip the client with grounding skills, distress tolerance, and emotion regulation before those memories surface is asking the client to face the worst of it without tools. The integrated approach reverses this order: stabilization and skills first, trauma processing later, and only when the primary therapist and client agree the timing is right.
Treatment levels of care
Integrated treatment for co-occurring PTSD and SUD is matched to severity. The American Society of Addiction Medicine (ASAM) describes a continuum of care that scales from outpatient counseling to medically managed inpatient treatment; the LOCUS framework (Level of Care Utilization System) parallels it on the mental-health side. For most adults with co-occurring PTSD and SUD, outpatient treatment is appropriate as long as the client is medically stable and not in acute psychiatric crisis.
The outpatient continuum runs from highest to lowest intensity:
| Level | What it looks like | Who it's for |
|---|---|---|
| Partial Care / Day Treatment | Full clinical day, 5 or 6 days per week | Significant functional impairment from PTSD and SUD; step-down from detox or inpatient |
| Intensive Outpatient (IOP) | 3 or 5 days per week, 3 clinical hours each | Moderate PTSD and SUD symptoms; step-down from Partial Care |
| Outpatient (OP) | Individual therapy, periodic groups | Continuing care; sustained stability with reduced clinical contact |
| Virtual Treatment | Same programming via secure video | Appropriate clinical presentation and home environment |
| Medical Detox | 24-hour medical monitoring (partner facility) | Active withdrawal management before outpatient programming |
Therapy approaches with the strongest evidence
No single therapy is the answer for co-occurring PTSD and SUD. Effective treatment combines a trauma-informed clinical posture across every interaction with a set of specific modalities that target the symptoms maintaining the disorder. The most well-supported approaches:
- Trauma-informed care is the universal posture, not a single technique. It means every group, every individual session, and every administrative interaction is paced and structured for clients with trauma histories: no required disclosure beyond client readiness, predictable structure, exit visibility, and respect for the client's window of tolerance.
- Cognitive behavioral therapy (CBT) principles adapted for trauma help clients identify the thoughts and situations that maintain trauma symptoms and substance use, and build coping skills that interrupt the pattern. See CBT for addiction.
- Dialectical behavior therapy (DBT) provides distress tolerance and emotion regulation skills that are central to managing hyperarousal, intrusive memories, and the urges to use substances that often follow them.
- Somatic grounding skills target hyperarousal and dissociation through the body, giving clients portable tools they can use in group, at home, and in environments where trauma cues are present.
- Narrative therapy helps clients construct a coherent account of their experience over time, without requiring exposure-style processing before the client is stabilized.
- Trauma-focused therapy in individual sessions is introduced when the primary therapist and client agree the timing is right, and never before the client has the grounding skills and distress tolerance to manage what comes up.
Medication considerations
Medication is a clinical decision, not a moral one, and for many clients with co-occurring PTSD and SUD, the right medication plan meaningfully improves outcomes. Several considerations apply specifically to this population:
- SSRIs (selective serotonin reuptake inhibitors) are first-line pharmacotherapy for PTSD. Sertraline and paroxetine carry FDA approval for PTSD; other SSRIs and SNRIs are used off-label with reasonable evidence.
- Prazosin is used for trauma-related nightmares and sleep disruption in many practice settings, particularly where sleep is a primary driver of distress.
- On-site psychiatric medication management lets the medical provider monitor mood, sleep, hyperarousal, and thoughts of suicide across treatment and adjust the medication plan as symptoms evolve, rather than handing the client off to an outside prescriber.
- MAT for co-occurring opioid or alcohol use disorder pairs the PTSD medication plan with SUD-focused medication: Suboxone (buprenorphine/naloxone) and Sublocade for opioid use disorder, and Vivitrol (long-acting naltrexone) for alcohol or opioid use disorder. Methadone is not on the formulary at The Archangel Centers; clients best served by methadone are referred to a federally licensed opioid treatment program.
- Benzodiazepines warrant particular caution in PTSD. The VA and Department of Defense Clinical Practice Guideline for PTSD recommends against routine use of benzodiazepines in PTSD, citing limited evidence of benefit, evidence of harm including worsened PTSD outcomes, and high risk of dependence, particularly in clients with co-occurring SUD.
What recovery from co-occurring PTSD and SUD looks like
Recovery from co-occurring PTSD and SUD is not a single event and not a fast process. The clinical literature is consistent on sequencing: stabilization first, trauma processing later. The temptation, particularly in the early weeks of sobriety, is to dive into the trauma narrative on the theory that the substances were covering it and now the work can begin. In practice, that approach floods the client, exceeds the window of tolerance, and often produces relapse. The work begins with grounding skills, distress tolerance, sleep, structure, and the basics of sober living.
The window-of-tolerance concept, developed by Dr. Daniel Siegel, describes the zone within which a person can experience emotion without becoming hyperaroused (overwhelmed, panicked, dissociated) or hypoaroused (shut down, numb, depressed). Trauma narrows the window; substances appear to widen it temporarily but actually narrow it further over time; recovery is largely the process of widening the window through skills, structure, and the slow integration of the underlying experience. Trauma-focused work is paced to stay within the widening window, not to blow past it.
Recovery from this combination tends to unfold over months and years, with setbacks. What predicts a durable outcome is the same set of factors that predict durable recovery from any co-occurring presentation:
- Treatment matched to severity, not the cheapest available
- PTSD and SUD treated in the same plan, by the same team, from admission, rather than sequentially
- Stabilization-first sequencing, with trauma processing introduced when the client and primary therapist agree on the timing
- A continuous relationship with a clinical team, not a one-time program
- Skills that work in the body, not just in the head: grounding, distress tolerance, emotion regulation
- Family involvement, where the family is willing and the client consents
- Time. Nervous-system regulation is a slow process. The work compounds over months.
What co-occurring conditions does Archangel treat?
PTSD is one of several mental health conditions that frequently co-occur with substance use disorder. Most adults entering treatment for SUD also meet criteria for at least one mental health condition; depression, generalized anxiety, post-traumatic stress, and bipolar disorder are the most common. The clinical evidence is clear: treating both at the same time, by the same team, produces better outcomes than treating them sequentially.
Frequently Asked Questions
How do I know I need PTSD and addiction treatment?
Will I have to talk about my trauma?
What if I am not ready to process trauma?
Do you use trauma-informed therapy?
Will I need psychiatric medication?
What if I am having suicidal thoughts?
What about hospitalization?
Can family participate?
Is methadone available?
How long is treatment?
Admissions are confidential and staffed 24/7 at (888) 464-2144. Or browse a specific clinic page for hours, address, and the full program.